APA (7th ed.) Citation

Kielkopf, M. C., Göcmen, J., Venzin, S. B., Steinauer, F., Branca, M., Boronylo, A., . . . Beyeler, M. (2025). Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer. Frontiers in neurology, 16, 1530775. https://doi.org/10.3389/fneur.2025.1530775

Chicago Style (17th ed.) Citation

Kielkopf, Moritz C., et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology 16 (2025): 1530775. https://doi.org/10.3389/fneur.2025.1530775.

MLA (9th ed.) Citation

Kielkopf, Moritz C., et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology, vol. 16, 2025, p. 1530775, https://doi.org/10.3389/fneur.2025.1530775.